Search Results

Insulin sensitisers and prompt revascularisation offer little cost benefit

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 592, 2009-11-28 , pp. 1-1(1)

Publisher: Adis International

Guidelines offer savings without compromising care

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 590, 2009-10-31 , pp. 8-8(1)

Publisher: Adis International

Variability in MI incidence casts doubt on large trials

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 1-1(1)

Publisher: Adis International

Increased CV risk with rosiglitazone but not pioglitazone

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 2-2(1)

Publisher: Adis International

Saxagliptin

Authors: Dhillon, Sohita; Weber, Juliane

Source: Drugs, Volume 69, Number 15, 22 October 2009 , pp. 2103-2114(12)

Publisher: Adis International

Treatment of diabetes suboptimal in US

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 585, 2009-08-22 , pp. 8-8(1)

Publisher: Adis International

Thiazolidinediones and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study of over 473 000 Patients Using the National Health Insurance Database in Taiwan

Authors: Hsiao, Fei-Yuan; Huang, Weng-Foung; Wen, Yu-Wen; Chen, Pei-Fen; Kuo, Ken N.; Tsai, Yi-Wen

Source: Drug Safety, Volume 32, Number 8, 8 August 2009 , pp. 675-690(16)

Publisher: Adis International

Philippines: essential drug prices to halve

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 583, 2009-07-25 , pp. 10-10(1)

Publisher: Adis International

Bone health in diabetes: considerations for clinical management

Author: Adami, Silvano

Source: Current Medical Research and Opinion, Volume 25, Number 5, May 2009 , pp. 1057-1072(16)

Publisher: Informa Healthcare

Persistent drug use provide economic benefits in DM

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 10-10(1)

Publisher: Adis International

Prevention and treatment of ischaemic heart disease are both important in patients with chronic kidney disease

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 6, June 2009 , pp. 19-21(3)

Publisher: Adis International

Nearly two thirds of prescription drug expenditure in the US was spent in five drug classes

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 572, 2009-02-21 , pp. 11-11(1)

Publisher: Adis International

Antihyperglycaemics: Transient hyperopia: 5 case reports

Source: Reactions, Volume 1, Number 1238, 2009-02-07 , pp. 5-5(1)

Publisher: Adis International

US FDA recommendations on cardio risk in diabetes trials

Source: Reactions, Volume 1, Number 1234, 2009-01-10 , pp. 2-2(1)

Publisher: Adis International

Chronic medication use on the rise in the younger population

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 566, 2008-11-15 , pp. 7-7(1)

Publisher: Adis International

Macrovascular disease prevention in T2DM: untangling the web

Source: Inpharma, Volume 1, Number 1665, 2008-11-22 , pp. 3-3(1)

Publisher: Adis International

Type 2 diabetes on the rise, says new study

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 567, 2008-11-29 , pp. 11-11(1)

Publisher: Adis International

Type 2 diabetes on the rise, says new study

Source: Inpharma, Volume 1, Number 1666, 2008-11-29 , pp. 4-4(1)

Publisher: Adis International

Drug samples influence generic prescriptions to uninsured

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 565, 2008-11-01 , pp. 6-6(1)

Publisher: Adis International

Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus

Author: Kabadi, Udaya M.

Source: Clinical Drug Investigation, Volume 28, Number 11, 2008 , pp. 697-701(5)

Publisher: Adis International